SOLNATIDE, the therapeutic molecule solnatide developed by APEPTICO for the treatment of various forms of life-threatening...Read More
The spread of Coronavirus continues both in Italy and globally.
For this reason, in order to protect the...Read More
Meet one of our delegates at one of the conferences below and find out how OPIS can assist you in your clinical drug development programmes.
OPIS is sponsoring the Clinical Operation in Oncology in Zurich, 27-28 November 2019.
Oncology is a milestone...Read More
19-21 November 2019: SAVE THE DATE! OPIS is one of the exhibitors who will participate in the next edition of Clinical...Read More